Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 6Recruiting 3Active not recruiting 3Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Papillomavirus Infections 2Warts 1Uterine Cervical Dysplasia 1Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT06658405 2026-03-18

HPV2

Centre Oscar Lambret

Phase 2 Recruiting
85 enrolled
Tumor-Agnostic

Neoplasms

NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT05625633 2024-04-05

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Western Institute for Veterans Research

Phase 2/3 Recruiting
120 enrolled

Warts, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡